Applied Genetic Technologies Corporation (AGTC) financial statements (2020 and earlier)

Company profile

Business Address 14193 NW 119TH TERRACE
ALACHUA, FL 32615
State of Incorp. DE
Fiscal Year End June 30
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:71821051279962
Cash and cash equivalents162731312939
Short-term investments555574967022
Other undisclosed cash, cash equivalents, and short-term investments(0)0    
Receivables000011
Other undisclosed current assets224332
Total current assets:738410913010364
Noncurrent Assets
Finance lease, right-of-use asset0
Operating lease, right-of-use asset4
Nontrade receivables     0
Property, plant and equipment445330
Long-term investments and receivables  2127424
Long-term investments  2127424
Intangible assets, net (including goodwill)111111
Intangible assets, net (excluding goodwill)111111
Other noncurrent assets111000
Other undisclosed noncurrent assets22 2  
Total noncurrent assets:1189187826
TOTAL ASSETS:859211914818190
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities143435
Accounts payable111111
Accrued liabilities     3
Employee-related liabilities 2222 
Taxes payable   2  
Debt1     
Deferred revenue and credits621  
Other undisclosed current liabilities765352 
Total current liabilities:991428555
Noncurrent Liabilities
Long-term debt and lease obligation5     
Finance lease, liability0
Operating lease, liability5
Liabilities, other than long-term debt245417 
Deferred revenue and credits1417 
Other liabilities244   
Total noncurrent liabilities:745417 
Total liabilities:17141933725
Stockholders' equity
Stockholders' equity attributable to parent68799911510986
Common stock000000
Treasury stock, value(0)(0)(0)   
Additional paid in capital215214210205199174
Accumulated deficit(147)(136)(111)(90)(90)(89)
Total stockholders' equity:68799911510986
TOTAL LIABILITIES AND EQUITY:859211914818190

Income statement (P&L) ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Revenue, net0012
Gross profit:28422439472
Operating expenses(45)(46)(47)(38)(49)(27)
Operating income (loss):(17)(4)(22)2(2)(25)
Nonoperating income221110
Investment income, nonoperating121110
Other nonoperating income (expense) 0(0)(0)(0)(0)
Interest and debt expense(0)     
Other undisclosed income from continuing operations before equity method investments, income taxes0     
Income (loss) from continuing operations before equity method investments, income taxes:(15)(2)(21)3(1)(24)
Loss from equity method investments(0)(0)    
Income (loss) from continuing operations before income taxes:(15)(2)(21)3(1)(24)
Income tax expense(0)(0)(0)(2)  
Income (loss) before gain (loss) on sale of properties:(15)(2)(21)0(1)(24)
Other undisclosed net loss  (0)   
Net income (loss) available to common stockholders, diluted:(15)(2)(21)0(1)(24)

Comprehensive Income ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Net income (loss):(15)(2)(21)0(1)(24)
Comprehensive income (loss), net of tax, attributable to parent:(15)(2)(21)0(1)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: